The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II clinical study of the efficacy and safety of adebrelimab in combination with lenvatinib as second-line treatment for advanced intrahepatic cholangiocarcinoma.
 
Chang Juan
No Relationships to Disclose
 
Di Wang
No Relationships to Disclose
 
Jiagan Huang
No Relationships to Disclose
 
Jianzhi Pang
No Relationships to Disclose
 
Wei Zhang
No Relationships to Disclose
 
Huifang Kong
No Relationships to Disclose
 
Huixin Zhang
No Relationships to Disclose
 
Xudong Gao
No Relationships to Disclose
 
Yinjie Gao
No Relationships to Disclose
 
Jiaqi Chen
No Relationships to Disclose
 
Jiali Zhao
No Relationships to Disclose
 
Aji Wang
No Relationships to Disclose
 
Yan Chen
No Relationships to Disclose
 
Yan Liu
No Relationships to Disclose
 
Zhenyu Zhu
No Relationships to Disclose
 
Zhen Zeng
No Relationships to Disclose